LexaGene Holdings (CVE: LXG – OTCQB: LXXGF) CEO Dr. Jack Regan joined Steve Darling from Proactive to share news the company is taking steps to list its common shares on the Nasdaq Capital Market with the goal of submitting its application prior to the end of 2021.
Regan shares with Proactive why the company is making the move and he also talks about some of the steps the company has already taken.